Literature DB >> 26858195

Amino Acid Metabolism is Altered in Adolescents with Nonalcoholic Fatty Liver Disease-An Untargeted, High Resolution Metabolomics Study.

Ran Jin1, Sophia Banton2, ViLinh T Tran2, Juna V Konomi1, Shuzhao Li2, Dean P Jones2, Miriam B Vos3.   

Abstract

OBJECTIVE: To conduct an untargeted, high resolution exploration of metabolic pathways that was altered in association with hepatic steatosis in adolescents. STUDY
DESIGN: This prospective, case-control study included 39 Hispanic-American, obese adolescents aged 11-17 years evaluated for hepatic steatosis using magnetic resonance spectroscopy. Of these 39 individuals, 30 had hepatic steatosis ≥5% and 9 were matched controls with hepatic steatosis <5%. Fasting plasma samples were analyzed in triplicate using ultra-high resolution metabolomics on a Thermo Fisher Q Exactive mass spectrometry system, coupled with C18 reverse phase liquid chromatography. Differences in plasma metabolites between adolescents with and without nonalcoholic fatty liver disease (NAFLD) were determined by independent t tests and visualized using Manhattan plots. Untargeted pathway analyses using Mummichog were performed among the significant metabolites to identify pathways that were most dysregulated in NAFLD.
RESULTS: The metabolomics analysis yielded 9583 metabolites, and 7711 with 80% presence across all samples remained for statistical testing. Of these, 478 metabolites were associated with the presence of NAFLD compared with the matched controls. Pathway analysis revealed that along with lipid metabolism, several major amino acid pathways were dysregulated in NAFLD, with tyrosine metabolism being the most affected.
CONCLUSIONS: Metabolic pathways of several amino acids are significantly disturbed in adolescents with elevated hepatic steatosis. This is a novel finding and suggests that these pathways may be integral in the mechanisms of NAFLD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26858195      PMCID: PMC5321134          DOI: 10.1016/j.jpeds.2016.01.026

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  32 in total

1.  apLCMS--adaptive processing of high-resolution LC/MS data.

Authors:  Tianwei Yu; Youngja Park; Jennifer M Johnson; Dean P Jones
Journal:  Bioinformatics       Date:  2009-05-04       Impact factor: 6.937

Review 2.  Genetic-related and carbohydrate-related factors affecting liver fat accumulation.

Authors:  Michael I Goran; Ryan Walker; Hooman Allayee
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-07       Impact factor: 4.294

3.  The footprints of gut microbial-mammalian co-metabolism.

Authors:  Xiaojiao Zheng; Guoxiang Xie; Aihua Zhao; Linjing Zhao; Chun Yao; Norman H L Chiu; Zhanxiang Zhou; Yuqian Bao; Weiping Jia; Jeremy K Nicholson; Wei Jia
Journal:  J Proteome Res       Date:  2011-10-24       Impact factor: 4.466

4.  Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy--a rapid and accurate technique.

Authors:  Nashiely Pineda; Puneet Sharma; Qin Xu; Xiaoping Hu; Miriam Vos; Diego R Martin
Journal:  Radiology       Date:  2009-06-22       Impact factor: 11.105

5.  Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease.

Authors:  Sulin Cheng; Petri Wiklund; Reija Autio; Ronald Borra; Xiaowei Ojanen; Leiting Xu; Timo Törmäkangas; Markku Alen
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

6.  Circulating metabolite predictors of glycemia in middle-aged men and women.

Authors:  Peter Würtz; Mika Tiainen; Ville-Petteri Mäkinen; Antti J Kangas; Pasi Soininen; Juha Saltevo; Sirkka Keinänen-Kiukaanniemi; Pekka Mäntyselkä; Terho Lehtimäki; Markku Laakso; Antti Jula; Mika Kähönen; Mauno Vanhala; Mika Ala-Korpela
Journal:  Diabetes Care       Date:  2012-05-04       Impact factor: 19.112

7.  Racial differences in nonalcoholic fatty liver disease in the U.S. population.

Authors:  Andrea L C Schneider; Mariana Lazo; Elizabeth Selvin; Jeanne M Clark
Journal:  Obesity (Silver Spring)       Date:  2013-06-11       Impact factor: 5.002

8.  Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults.

Authors:  Peter Würtz; Pasi Soininen; Antti J Kangas; Tapani Rönnemaa; Terho Lehtimäki; Mika Kähönen; Jorma S Viikari; Olli T Raitakari; Mika Ala-Korpela
Journal:  Diabetes Care       Date:  2012-11-05       Impact factor: 19.112

9.  Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease.

Authors:  Sonia Michail; Malinda Lin; Mark R Frey; Rob Fanter; Oleg Paliy; Brian Hilbush; Nicholas V Reo
Journal:  FEMS Microbiol Ecol       Date:  2014-12-05       Impact factor: 4.519

Review 10.  Environmental pollution: a tangible risk for NAFLD pathogenesis.

Authors:  Mario Arciello; Manuele Gori; Roberta Maggio; Barbara Barbaro; Mirko Tarocchi; Andrea Galli; Clara Balsano
Journal:  Int J Mol Sci       Date:  2013-11-07       Impact factor: 5.923

View more
  30 in total

1.  Serum metabolites detect the presence of advanced fibrosis in derivation and validation cohorts of patients with non-alcoholic fatty liver disease.

Authors:  Cyrielle Caussy; Veeral H Ajmera; Puneet Puri; Cynthia Li-Shin Hsu; Shirin Bassirian; Mania Mgdsyan; Seema Singh; Claire Faulkner; Mark A Valasek; Emily Rizo; Lisa Richards; David A Brenner; Claude B Sirlin; Arun J Sanyal; Rohit Loomba
Journal:  Gut       Date:  2018-12-19       Impact factor: 23.059

Review 2.  Metabolomics and Metabolic Diseases: Where Do We Stand?

Authors:  Christopher B Newgard
Journal:  Cell Metab       Date:  2016-10-27       Impact factor: 27.287

Review 3.  Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  Metabolites       Date:  2020-01-28

4.  Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD.

Authors:  Cyrielle Caussy; Cynthia Hsu; Min-Tzu Lo; Amy Liu; Ricki Bettencourt; Veeral H Ajmera; Shirin Bassirian; Jonathan Hooker; Ethan Sy; Lisa Richards; Nicholas Schork; Bernd Schnabl; David A Brenner; Claude B Sirlin; Chi-Hua Chen; Rohit Loomba
Journal:  Hepatology       Date:  2018-05-20       Impact factor: 17.425

5.  Sex-Specific Metabolite Biomarkers of NAFLD in Youth: A Prospective Study in the EPOCH Cohort.

Authors:  Wei Perng; Ellen C Francis; Harry A Smith; John Carey; Dongqing Wang; Katerina M Kechris; Dana Dabelea
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

6.  Metabolome-wide association study of peripheral parasitemia in Plasmodium vivax malaria.

Authors:  Luiz Gustavo Gardinassi; Regina Joice Cordy; Marcus V G Lacerda; Jorge L Salinas; Wuelton M Monteiro; Gisely C Melo; André M Siqueira; Fernando F Val; ViLinh Tran; Dean P Jones; Mary R Galinski; Shuzhao Li
Journal:  Int J Med Microbiol       Date:  2017-09-06       Impact factor: 3.473

Review 7.  Computational Metabolomics: A Framework for the Million Metabolome.

Authors:  Karan Uppal; Douglas I Walker; Ken Liu; Shuzhao Li; Young-Mi Go; Dean P Jones
Journal:  Chem Res Toxicol       Date:  2016-10-12       Impact factor: 3.739

Review 8.  Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease.

Authors:  Peter R Baker; Jacob E Friedman
Journal:  J Clin Invest       Date:  2018-08-31       Impact factor: 14.808

9.  Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach.

Authors:  Ran Jin; Rob McConnell; Cioffi Catherine; Shujing Xu; Douglas I Walker; Nikos Stratakis; Dean P Jones; Gary W Miller; Cheng Peng; David V Conti; Miriam B Vos; Leda Chatzi
Journal:  Environ Int       Date:  2019-11-16       Impact factor: 13.352

10.  Prenatal Exposure to Perfluoroalkyl Substances Associated With Increased Susceptibility to Liver Injury in Children.

Authors:  Nikos Stratakis; David V Conti; Ran Jin; Katerina Margetaki; Damaskini Valvi; Alexandros P Siskos; Léa Maitre; Erika Garcia; Nerea Varo; Yinqi Zhao; Theano Roumeliotaki; Marina Vafeiadi; Jose Urquiza; Silvia Fernández-Barrés; Barbara Heude; Xavier Basagana; Maribel Casas; Serena Fossati; Regina Gražulevičienė; Sandra Andrušaitytė; Karan Uppal; Rosemary R C McEachan; Eleni Papadopoulou; Oliver Robinson; Line Småstuen Haug; John Wright; Miriam B Vos; Hector C Keun; Martine Vrijheid; Kiros T Berhane; Rob McConnell; Lida Chatzi
Journal:  Hepatology       Date:  2020-10-19       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.